“I’m continually amazed by the breadth and depth of experience in science and biotech company creation contained in one tight Third Rock family.”
As an EIR in our San Francisco office, Peter is building our next wave of transformational drug discovery companies. He focuses on the alignment of emerging science and company strategy, and building world-class teams to execute on new opportunities. He is enthusiastic about the insights that human genetics and data sciences will provide to enable us to more deeply understand and treat previously intractable diseases.
Driven by a passion for the role of emerging technologies in drug discovery, Peter has over 20 years of experience in the life sciences industry, and his career has spanned therapeutic platforms, genomics technologies, systems biology tools, and data sciences.
One of Peter's greatest accomplishments is finishing the New York City Marathon (although Peter acknowledges that the statute of limitation to claim this as an accomplishment has probably expired).